IGC Pharma (IGC) Shareholder's Equity (2011 - 2026)

IGC Pharma (IGC) Shareholder's Equity (2011 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - 7.14 Bn
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - 795.79 Mn
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - 595,226.00
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 1.00 Bn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - 14.38 Mn
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 19.36 Bn
9 Abivax 94.37 Bn 94.37 Bn - 502.95 Mn
10 IGC Pharma 29.33 Mn 29.07 Mn - 6.12 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 6.12 Mn
Dec 31, 2025 7.42 Mn
Sep 30, 2025 8.09 Mn
Jun 30, 2025 6.08 Mn
Mar 31, 2025 6.33 Mn
Dec 31, 2024 6.26 Mn
Sep 30, 2024 7.38 Mn
Jun 30, 2024 7.88 Mn
Mar 31, 2024 7.32 Mn
Dec 31, 2023 9.05 Mn
Sep 30, 2023 14.10 Mn
Jun 30, 2023 13.20 Mn
Mar 31, 2023 14.91 Mn
Dec 31, 2022 18.32 Mn
Sep 30, 2022 20.14 Mn
Jun 30, 2022 22.04 Mn
Mar 31, 2022 23.89 Mn
Dec 31, 2021 29.48 Mn
Sep 30, 2021 31.26 Mn
Jun 30, 2021 31.74 Mn